House Speaker Nancy Pelosi’s bill to let the government negotiate prices on some drugs would save the government $ 345 billion over seven years but stifle innovation of new treatments and cures, according to a new analysis from the Congressional Budget Office. Democrats are likely to use the findings, from an initial report from the… Read More »
As the partial government shutdown of 2018 extends into 2019, the speed at which new drugs are approved by the Food and Drug Administration (FDA) may decrease. Starting on Wednesday, January 2, the FDA began to furlough 40 percent of its staff, according to a report by National Public Radio. The agency will continue to… Read More »
Editorial pages focus on these health care issues and others. The Hill: Preventing The Next Romaine Lettuce E. Coli Outbreak Seven years after Congress passed the 2011 Food Safety Modernization Act (FSMA), the FDA still hasn’t implemented a number of key reforms required by that law. Among other things, the law required the FDA to… Read More »